Evidence map›Paper›PMID 38238535›Full record

ArticleBiological trace element research2024

Mitigation of Acute Hepatotoxicity Induced by Cadmium Through Morin: Modulation of Oxidative and Pro-apoptotic Endoplasmic Reticulum Stress and Inflammatory Responses in Rats.

Emin Sengul, Serkan Yildirim, İrfan Cinar, Samet Tekin, Yusuf Dag, Merve Bolat, Melahat Gok, Mohamad Warda

Open access · hybridAbstract read
In one paragraph

Article in Biological trace element research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Nifuroxazide Pretreatment Protects Against Acute CdClAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Emin SengulDepartment of Physiology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey. emin.sengul97@gmail.com.ORCID http://orcid.org/0000-0003-1566-1816
Serkan YildirimDepartment of Pathology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
İrfan CinarDepartment of Pharmacology, Faculty of Medicine, Kastamonu University, Kastamonu, Turkey.
Samet TekinDepartment of Physiology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Yusuf DagDepartment of Physiology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Merve BolatDepartment of Physiology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Melahat GokDepartment of Physiology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Mohamad WardaDepartment of Physiology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Atatürk University · TRCairo University · EGKastamonu University · TR

Funding

Ataturk University Scientific Research Projects Coordination Unit TCD-2020-8726
6 · The paper itself

Abstract

Cadmium (Cd) is a toxic heavy metal with significant environmental health hazards. It enters the body through various routes with tissue accumulation. The relatively longer half-life with slow body clearance significantly results in hepatotoxicity during its liver detoxification. Therefore, researchers are exploring the potential use of herbal-derived phytocomponents to mitigate their toxicity. Here, we investigated, for the first time, the possible ameliorative effect of the phytochemical Morin (3,5,7,29,49-pentahydroxyflavone) against acute Cd-induced hepatotoxicity while resolving its underlying cellular mechanisms in a rat animal model. The study involved 50 adult male Sprague-Dawley rats weighing 200-250 g. The animals were divided into five equal groups: control, Cd, Morin100 + Cd, Morin200 + Cd, and Morin200. The 2nd, 3rd, and 4th groups were intraperitoneally treated with Cd (6.5 mg/kg), while the 3rd, 4th, and 5th groups were orally treated with Morin (100 and 200 mg/kg) for 5 consecutive days. On the 6th day, hepatic function (serum ALT, AST, ALP, LDH enzyme activities, and total bilirubin level) testing, transcriptome analysis, and immunohistochemistry were performed to elucidate the ameliorative effect of Morin on hepatotoxicity. In addition to restoring liver function and tissue injury, Morin alleviated Cd-induced hepatic oxidative/endoplasmic reticulum stress in a dose-dependent manner, as revealed by upregulating the expression of antioxidants (SOD, GSH, Gpx, CAT, and Nrf2) and decreasing the expression of ER stress markers. The expression of the proinflammatory mediators (TNF-α, IL-1-β, and IL-6) was also downregulated while improving the anti-inflammatory (IL-10 and IL-4) expression levels. Morin further slowed the apoptotic cascades by deregulating the expression of pro-apoptotic Bax and Caspase 12 markers concomitant with an increase in anti-apoptotic Blc2 mRNA expression. Furthermore, Morin restored Cd-induced tissue damage and markedly suppressed the cytoplasmic expression of JNK and p-PERK immunostained proteins. This study demonstrated the dose-dependent antioxidant hepatoprotective effect of Morin against acute hepatic Cd intoxication. This effect is likely linked with the modulation of upstream p-GRP78/PERK/ATF6 pro-apoptotic oxidative/ER stress and the downstream JNK/BAX/caspase 12 apoptotic signaling pathways.

Indexed as

AntioxidantsCadmiumChemical and Drug Induced Liver InjuryEndoplasmic Reticulum StressFlavonesHepatitis, AnimalOxidative StressAnimalsApoptosisBody WeightMaleRatsRats, Sprague-DawleyAntioxidantsCadmiumFlavonesmorinCadmiumEndoplasmic reticulum stressHepatotoxicityInflammationMorinRat

Identifiers

PMID38238535
PMCPMC11442647
OpenAlexW4391005276

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.